Is Aytu Biopharma Stock a good buy in 2025, according to Wall Street analysts?
The consensus among 2 Wall Street analysts covering (NASDAQ: AYTU) stock is to Strong Buy AYTU stock.
Out of 2 analysts, 1 (50%) are recommending AYTU as a Strong Buy, 1 (50%) are recommending AYTU as a Buy, 0 (0%) are recommending AYTU as a Hold, 0 (0%) are recommending AYTU as a Sell, and 0 (0%) are recommending AYTU as a Strong Sell.
What is AYTU's earnings growth forecast for 2026-2026?
(NASDAQ: AYTU) Aytu Biopharma's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 127.7%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 52.79%.
Aytu Biopharma's earnings in 2025 is $1,639,000.
In 2026, AYTU is forecast to generate -$2,468,098 in earnings, with the lowest earnings forecast at -$2,468,098 and the highest earnings forecast at -$2,468,098.
What is AYTU's revenue growth forecast for 2026-2026?
(NASDAQ: AYTU) Aytu Biopharma's forecast annual revenue growth rate of 4.01% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 2.69%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 55.02%.
Aytu Biopharma's revenue in 2025 is $69,223,000.
In 2026, AYTU is forecast to generate $444,257,712 in revenue, with the lowest revenue forecast at $444,257,712 and the highest revenue forecast at $444,257,712.
What is AYTU's forecast return on assets (ROA) for 2026-2026?
(NASDAQ: AYTU) forecast ROA is -1.99%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 12.18%.
What is AYTU's Price Target?
According to 2 Wall Street analysts that have issued a 1 year AYTU price target, the average AYTU price target is $10.00, with the highest AYTU stock price forecast at $12.00 and the lowest AYTU stock price forecast at $8.00.
On average, Wall Street analysts predict that Aytu Biopharma's share price could reach $10.00 by Jul 1, 2026. The average Aytu Biopharma stock price prediction forecasts a potential upside of 309.84% from the current AYTU share price of $2.44.
What is AYTU's Earnings Per Share (EPS) forecast for 2026-2026?
(NASDAQ: AYTU) Aytu Biopharma's current Earnings Per Share (EPS) is $0.20. In 2026, AYTU's EPS is forecast to hit -$0.40 (min: -$0.40, max: -$0.40).
What is AYTU's forecast return on equity (ROE) for 2026-2026?
(NASDAQ: AYTU) forecast ROE is -7.07%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.